These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23744158)

  • 1. Progress toward treatments for synaptic defects in autism.
    Delorme R; Ey E; Toro R; Leboyer M; Gillberg C; Bourgeron T
    Nat Med; 2013 Jun; 19(6):685-94. PubMed ID: 23744158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders.
    Santini E; Klann E
    Sci Signal; 2014 Oct; 7(349):re10. PubMed ID: 25351249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches for shankopathies.
    Wang X; Bey AL; Chung L; Krystal AD; Jiang YH
    Dev Neurobiol; 2014 Feb; 74(2):123-35. PubMed ID: 23536326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscapes of autism spectrum disorders.
    Huguet G; Ey E; Bourgeron T
    Annu Rev Genomics Hum Genet; 2013; 14():191-213. PubMed ID: 23875794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of autism spectrum disorder (ASD): a synaptic-level approach to autistic-like behavior in mice.
    Shinoda Y; Sadakata T; Furuichi T
    Exp Anim; 2013; 62(2):71-8. PubMed ID: 23615300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic analyses for identifying molecular mechanisms in autism spectrum disorders].
    Chiocchetti A; Klauck SM
    Z Kinder Jugendpsychiatr Psychother; 2011 Mar; 39(2):101-11. PubMed ID: 21442598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders.
    Toro R; Konyukh M; Delorme R; Leblond C; Chaste P; Fauchereau F; Coleman M; Leboyer M; Gillberg C; Bourgeron T
    Trends Genet; 2010 Aug; 26(8):363-72. PubMed ID: 20609491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain mechanisms of plasticity in response to treatments for core deficits in autism.
    Ventola PE; Oosting D; Anderson LC; Pelphrey KA
    Prog Brain Res; 2013; 207():255-72. PubMed ID: 24309258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.
    Canitano R
    Behav Brain Res; 2013 Aug; 251():125-32. PubMed ID: 23202136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor dysfunction in autism spectrum disorders.
    Lee EJ; Choi SY; Kim E
    Curr Opin Pharmacol; 2015 Feb; 20():8-13. PubMed ID: 25636159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
    Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
    J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles.
    Wöhr M
    Neurosci Biobehav Rev; 2014 Jun; 43():199-212. PubMed ID: 24726578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics and animal modeling of autism spectrum disorders. New developments].
    Klauck SM; Poustka L; Chiocchetti A
    Nervenarzt; 2011 May; 82(5):553-62. PubMed ID: 21472451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers.
    Meyza KZ; Defensor EB; Jensen AL; Corley MJ; Pearson BL; Pobbe RL; Bolivar VJ; Blanchard DC; Blanchard RJ
    Behav Brain Res; 2013 Aug; 251():25-34. PubMed ID: 22958973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A blueprint for research on Shankopathies: a view from research on autism spectrum disorder.
    Carbonetto S
    Dev Neurobiol; 2014 Feb; 74(2):85-112. PubMed ID: 24218108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context.
    Sungur AÖ; Vörckel KJ; Schwarting RK; Wöhr M
    J Neurosci Methods; 2014 Aug; 234():92-100. PubMed ID: 24820912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders.
    Pignatelli M; Feligioni M; Piccinin S; Molinaro G; Nicoletti F; Nisticò R
    Curr Pharm Des; 2013; 19(36):6480-90. PubMed ID: 23432715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral profiles of mouse models for autism spectrum disorders.
    Ey E; Leblond CS; Bourgeron T
    Autism Res; 2011 Feb; 4(1):5-16. PubMed ID: 21328568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant mouse models of autism spectrum disorders.
    Provenzano G; Zunino G; Genovesi S; Sgadó P; Bozzi Y
    Dis Markers; 2012; 33(5):225-39. PubMed ID: 22960336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity and convergence: the synaptic pathophysiology of autism.
    Baudouin SJ
    Eur J Neurosci; 2014 Apr; 39(7):1107-13. PubMed ID: 24712990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.